Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/66446| metadata.dc.identifier.doi: | https://doi.org/10.56042/jipr.v30i5.7865 |
| Title: | Public Policy Reflection on Commercialization of Pharmaceutical Patents in India: A Legal Introspect |
| Authors: | Thaorey, Payal Mukte, Anushree |
| Keywords: | Intellectual Property Rights;Patents;Pharmaceutical Patents;India;Public Policy;Right to Health;Commercialization of Pharmaceutical Patents;Compulsory Licensing;Affordability of Medicines;Economic- Monopolistic Approach of Patent |
| Issue Date: | Sep-2025 |
| Publisher: | NIScPR-CSIR, India |
| Abstract: | Public policy, right to health, affordable medicines and patenting of medicines are closely knitted phenomena for fulfilment of individual and public interest imperatives. This article attempts to analyse the impact of patenting and commercialization of the medicines with and against materialization of right to health for all. The welfare aspects public policy that provides for availability and affordability of medicines for all and its applicability with respect to patenting and commercialization of medicines is examined in light of specific issues as followsi. Primarily, whether the existing patent policy in specific is responsive to public policy in general. ii. Secondly, to what extent public policy shall be incorporated in commercialization of pharmaceutical patents? iii. Thirdly, to what extent commercialization of pharmaceutical patents can be compromised for execution of public policy? iv. Fourthly, is there any possibility of balancing mechanism wherein both, commercialization and public policy with respect to pharmaceutical patents can be maintained? |
| Page(s): | 537-549 |
| ISSN: | 0975-1076 (Online); 0971-7544 (Print) |
| Appears in Collections: | JIPR Vol.30(5) [September 2025] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| JIPR-30(5) 537-549.pdf | 272.68 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.